Merck & Co., Inc. MRK
NYSE · United States · Health Technology
$145.31-3.97 (-2.66%)
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Market closed· · USD · Data may be delayed
Prices may be delayed and are for informational purposes only - not investment advice.
Total return, dividends included.
Where the price sits against its 50- and 200-day moving averages.
Makkler Fair Value, financial health score, analyst view, peers and MakklerAI.
The decline outpaced the S&P 500 as Merck’s October earnings report approaches, with consensus forecasts pointing to lower quarterly earnings.
Johnson & Johnson shares climbed despite slower revenue growth, as investors weigh new-drug momentum against Stelara losses and softer MedTech sales.
The Florida Republican disclosed a cluster of August trades spanning SpaceX, Berkshire Hathaway, biotech and technology stocks.